Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine butyl bromide for shortening the active phase of labor in primigravida women in Uganda
PACTR202601714326960Recruiting
- Sponsor
- Aisha Abdullahi Ahmed
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of hyoscine butylbromide in childbirth (2 arms), sponsored by Aisha Abdullahi Ahmed. Primary endpoint: Duration of the active phase of labour. Started Jan 2026; status: recruiting.
02
Drugs
hyoscine butylbromide
03
Conditions
childbirth
Beyond the preview
Go deeper on PACTR202601714326960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202601714326960.